Xenodiagnosis to Detect Borrelia burgdorferi Infection: A First-in-Human Study
Background. Animal studies suggest that Borrelia burgdorferi, the agent of Lyme disease, may persist after antibiotic therapy and can be detected by various means including xenodiagnosis using the natural tick vector (Ixodes scapularis). No convincing evidence exists for the persistence of viable sp...
Saved in:
Published in | Clinical infectious diseases Vol. 58; no. 7; pp. 937 - 945 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford
OXFORD UNIVERSITY PRESS
01.04.2014
Oxford University Press |
Subjects | |
Online Access | Get full text |
ISSN | 1058-4838 1537-6591 1537-6591 |
DOI | 10.1093/cid/cit939 |
Cover
Loading…
Abstract | Background. Animal studies suggest that Borrelia burgdorferi, the agent of Lyme disease, may persist after antibiotic therapy and can be detected by various means including xenodiagnosis using the natural tick vector (Ixodes scapularis). No convincing evidence exists for the persistence of viable spirochetes after recommended courses of antibiotic therapy in humans. We determined the safety of using I. scapularis larvae for the xenodiagnosis of B. burgdorferi infection in humans. Methods. Laboratory-reared larval I. scapularis ticks were placed on 36 subjects and allowed to feed to repletion. Ticks were tested for B. burgdorferi by polymerase chain reaction (PCR), culture, and/or isothermal amplification followed by PCR and electrospray ionization mass spectroscopy. In addition, attempts were made to infect immunodeficient mice by tick bite or inoculation of tick contents. Xenodiagnosis was repeated in 7 individuals. Results. Xenodiagnosis was well tolerated with no severe adverse events. The most common adverse event was mild itching at the tick attachment site. Xenodiagnosis was negative in 16 patients with posttreatment Lyme disease syndrome (PTLDS) and/or high C6 antibody levels and in 5 patients after completing antibiotic therapy for erythema migrans. Xenodiagnosis was positive for B. burgdorferi DNA in a patient with erythema migrans early during therapy and in a patient with PTLDS. There is insufficient evidence, however, to conclude that viable spirochetes were present in either patient. Conclusions. Xenodiagnosis using Ixodes scapularis larvae was safe and well tolerated. Further studies are needed to determine the sensitivity of xenodiagnosis in patients with Lyme disease and the significance of a positive result. Clinical Trials Registration. NCT01143558. |
---|---|
AbstractList | Animal studies suggest that Borrelia burgdorferi, the agent of Lyme disease, may persist after antibiotic therapy and can be detected by various means including xenodiagnosis using the natural tick vector (Ixodes scapularis). No convincing evidence exists for the persistence of viable spirochetes after recommended courses of antibiotic therapy in humans. We determined the safety of using I. scapularis larvae for the xenodiagnosis of B. burgdorferi infection in humans.BACKGROUNDAnimal studies suggest that Borrelia burgdorferi, the agent of Lyme disease, may persist after antibiotic therapy and can be detected by various means including xenodiagnosis using the natural tick vector (Ixodes scapularis). No convincing evidence exists for the persistence of viable spirochetes after recommended courses of antibiotic therapy in humans. We determined the safety of using I. scapularis larvae for the xenodiagnosis of B. burgdorferi infection in humans.Laboratory-reared larval I. scapularis ticks were placed on 36 subjects and allowed to feed to repletion. Ticks were tested for B. burgdorferi by polymerase chain reaction (PCR), culture, and/or isothermal amplification followed by PCR and electrospray ionization mass spectroscopy. In addition, attempts were made to infect immunodeficient mice by tick bite or inoculation of tick contents. Xenodiagnosis was repeated in 7 individuals.METHODSLaboratory-reared larval I. scapularis ticks were placed on 36 subjects and allowed to feed to repletion. Ticks were tested for B. burgdorferi by polymerase chain reaction (PCR), culture, and/or isothermal amplification followed by PCR and electrospray ionization mass spectroscopy. In addition, attempts were made to infect immunodeficient mice by tick bite or inoculation of tick contents. Xenodiagnosis was repeated in 7 individuals.Xenodiagnosis was well tolerated with no severe adverse events. The most common adverse event was mild itching at the tick attachment site. Xenodiagnosis was negative in 16 patients with posttreatment Lyme disease syndrome (PTLDS) and/or high C6 antibody levels and in 5 patients after completing antibiotic therapy for erythema migrans. Xenodiagnosis was positive for B. burgdorferi DNA in a patient with erythema migrans early during therapy and in a patient with PTLDS. There is insufficient evidence, however, to conclude that viable spirochetes were present in either patient.RESULTSXenodiagnosis was well tolerated with no severe adverse events. The most common adverse event was mild itching at the tick attachment site. Xenodiagnosis was negative in 16 patients with posttreatment Lyme disease syndrome (PTLDS) and/or high C6 antibody levels and in 5 patients after completing antibiotic therapy for erythema migrans. Xenodiagnosis was positive for B. burgdorferi DNA in a patient with erythema migrans early during therapy and in a patient with PTLDS. There is insufficient evidence, however, to conclude that viable spirochetes were present in either patient.Xenodiagnosis using Ixodes scapularis larvae was safe and well tolerated. Further studies are needed to determine the sensitivity of xenodiagnosis in patients with Lyme disease and the significance of a positive result. Clinical Trials Registration NCT01143558.CONCLUSIONSXenodiagnosis using Ixodes scapularis larvae was safe and well tolerated. Further studies are needed to determine the sensitivity of xenodiagnosis in patients with Lyme disease and the significance of a positive result. Clinical Trials Registration NCT01143558. Animal studies suggest that Borrelia burgdorferi, the agent of Lyme disease, may persist after antibiotic therapy and can be detected by various means including xenodiagnosis using the natural tick vector (Ixodes scapularis). No convincing evidence exists for the persistence of viable spirochetes after recommended courses of antibiotic therapy in humans. We determined the safety of using I. scapularis larvae for the xenodiagnosis of B. burgdorferi infection in humans. Laboratory-reared larval I. scapularis ticks were placed on 36 subjects and allowed to feed to repletion. Ticks were tested for B. burgdorferi by polymerase chain reaction (PCR), culture, and/or isothermal amplification followed by PCR and electrospray ionization mass spectroscopy. In addition, attempts were made to infect immunodeficient mice by tick bite or inoculation of tick contents. Xenodiagnosis was repeated in 7 individuals. Xenodiagnosis was well tolerated with no severe adverse events. The most common adverse event was mild itching at the tick attachment site. Xenodiagnosis was negative in 16 patients with posttreatment Lyme disease syndrome (PTLDS) and/or high C6 antibody levels and in 5 patients after completing antibiotic therapy for erythema migrans. Xenodiagnosis was positive for B. burgdorferi DNA in a patient with erythema migrans early during therapy and in a patient with PTLDS. There is insufficient evidence, however, to conclude that viable spirochetes were present in either patient. Xenodiagnosis using Ixodes scapularis larvae was safe and well tolerated. Further studies are needed to determine the sensitivity of xenodiagnosis in patients with Lyme disease and the significance of a positive result. Clinical Trials Registration NCT01143558. Background. Animal studies suggest that Borrelia burgdorferi, the agent of Lyme disease, may persist after antibiotic therapy and can be detected by various means including xenodiagnosis using the natural tick vector (Ixodes scapularis). No convincing evidence exists for the persistence of viable spirochetes after recommended courses of antibiotic therapy in humans. We determined the safety of using I. scapularis larvae for the xenodiagnosis of B. burgdorferi infection in humans. Methods. Laboratory-reared larval I. scapularis ticks were placed on 36 subjects and allowed to feed to repletion. Ticks were tested for B. burgdorferi by polymerase chain reaction (PCR), culture, and/or isothermal amplification followed by PCR and electrospray ionization mass spectroscopy. In addition, attempts were made to infect immunodeficient mice by tick bite or inoculation of tick contents. Xenodiagnosis was repeated in 7 individuals. Results. Xenodiagnosis was well tolerated with no severe adverse events. The most common adverse event was mild itching at the tick attachment site. Xenodiagnosis was negative in 16 patients with posttreatment Lyme disease syndrome (PTLDS) and/or high C6 antibody levels and in 5 patients after completing antibiotic therapy for erythema migrans. Xenodiagnosis was positive for B. burgdorferi DNA in a patient with erythema migrans early during therapy and in a patient with PTLDS. There is insufficient evidence, however, to conclude that viable spirochetes were present in either patient. Conclusions. Xenodiagnosis using Ixodes scapularis larvae was safe and well tolerated. Further studies are needed to determine the sensitivity of xenodiagnosis in patients with Lyme disease and the significance of a positive result. Clinical Trials Registration. NCT01143558. Animal studies suggest that Borrelia burgdorferi, the agent of Lyme disease, may persist after antibiotic therapy and can be detected by various means including xenodiagnosis using the natural tick vector (Ixodes scapularis). No convincing evidence exists for the persistence of viable spirochetes after recommended courses of antibiotic therapy in humans. We determined the safety of using I. scapularis larvae for the xenodiagnosis of B. burgdorferi infection in humans. Laboratory-reared larval I. scapularis ticks were placed on 36 subjects and allowed to feed to repletion. Ticks were tested for B. burgdorferi by polymerase chain reaction (PCR), culture, and/or isothermal amplification followed by PCR and electrospray ionization mass spectroscopy. In addition, attempts were made to infect immunodeficient mice by tick bite or inoculation of tick contents. Xenodiagnosis was repeated in 7 individuals. Xenodiagnosis was well tolerated with no severe adverse events. The most common adverse event was mild itching at the tick attachment site. Xenodiagnosis was negative in 16 patients with posttreatment Lyme disease syndrome (PTLDS) and/or high C6 antibody levels and in 5 patients after completing antibiotic therapy for erythema migrans. Xenodiagnosis was positive for B. burgdorferi DNA in a patient with erythema migrans early during therapy and in a patient with PTLDS. There is insufficient evidence, however, to conclude that viable spirochetes were present in either patient. Xenodiagnosis using Ixodes scapularis larvae was safe and well tolerated. Further studies are needed to determine the sensitivity of xenodiagnosis in patients with Lyme disease and the significance of a positive result. Xenodiagnosis using Ixodes scapularis larvae in humans is safe and well tolerated. There is no evidence of persistence of infection after antibiotic therapy in the majority of individuals. Background. Animal studies suggest that Borrelia burgdorferi , the agent of Lyme disease, may persist after antibiotic therapy and can be detected by various means including xenodiagnosis using the natural tick vector ( Ixodes scapularis ). No convincing evidence exists for the persistence of viable spirochetes after recommended courses of antibiotic therapy in humans. We determined the safety of using I. scapularis larvae for the xenodiagnosis of B. burgdorferi infection in humans. Methods. Laboratory-reared larval I. scapularis ticks were placed on 36 subjects and allowed to feed to repletion. Ticks were tested for B. burgdorferi by polymerase chain reaction (PCR), culture, and/or isothermal amplification followed by PCR and electrospray ionization mass spectroscopy. In addition, attempts were made to infect immunodeficient mice by tick bite or inoculation of tick contents. Xenodiagnosis was repeated in 7 individuals. Results. Xenodiagnosis was well tolerated with no severe adverse events. The most common adverse event was mild itching at the tick attachment site. Xenodiagnosis was negative in 16 patients with posttreatment Lyme disease syndrome (PTLDS) and/or high C6 antibody levels and in 5 patients after completing antibiotic therapy for erythema migrans. Xenodiagnosis was positive for B. burgdorferi DNA in a patient with erythema migrans early during therapy and in a patient with PTLDS. There is insufficient evidence, however, to conclude that viable spirochetes were present in either patient. Conclusions. Xenodiagnosis using Ixodes scapularis larvae was safe and well tolerated. Further studies are needed to determine the sensitivity of xenodiagnosis in patients with Lyme disease and the significance of a positive result. Clinical Trials Registration NCT01143558. |
Author | Dardick, Kenneth Krause, Peter J. Carolan, Heather E. Marques, Adriana Telford, Sam R. Eshoo, Mark W. Turk, Siu-Ping Brandeburg, Christina Shaw, Pamela A. Hu, Linden T. Chung, Erin Crowder, Christopher D. Williams, Carla |
AuthorAffiliation | 2 Department of Infectious Disease and Global Health , Cummings School of Veterinary Medicine, Tufts University 6 Department of Epidemiology of Microbial Diseases , Yale School of Public Health, Yale School of Medicine, New Haven, Connecticut 1 Laboratory of Clinical Infectious Diseases , National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 3 Department of Medicine, Division of Geographic Medicine and Infectious Diseases , Tufts Medical Center, Boston, Massachusetts 5 Mansfield Family Practice, Storrs 7 Ibis Biosciences , Inc., a subsidiary of Abbott Company, Carlsbad, California 8 Biostatistics Research Branch , National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 4 SAIC-Frederick, Inc., NCI-Frederick , Maryland |
AuthorAffiliation_xml | – name: 3 Department of Medicine, Division of Geographic Medicine and Infectious Diseases , Tufts Medical Center, Boston, Massachusetts – name: 6 Department of Epidemiology of Microbial Diseases , Yale School of Public Health, Yale School of Medicine, New Haven, Connecticut – name: 7 Ibis Biosciences , Inc., a subsidiary of Abbott Company, Carlsbad, California – name: 8 Biostatistics Research Branch , National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland – name: 4 SAIC-Frederick, Inc., NCI-Frederick , Maryland – name: 2 Department of Infectious Disease and Global Health , Cummings School of Veterinary Medicine, Tufts University – name: 1 Laboratory of Clinical Infectious Diseases , National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland – name: 5 Mansfield Family Practice, Storrs |
Author_xml | – sequence: 1 givenname: Adriana surname: Marques fullname: Marques, Adriana – sequence: 2 givenname: Sam R. surname: Telford fullname: Telford, Sam R. – sequence: 3 givenname: Siu-Ping surname: Turk fullname: Turk, Siu-Ping – sequence: 4 givenname: Erin surname: Chung fullname: Chung, Erin – sequence: 5 givenname: Carla surname: Williams fullname: Williams, Carla – sequence: 6 givenname: Kenneth surname: Dardick fullname: Dardick, Kenneth – sequence: 7 givenname: Peter J. surname: Krause fullname: Krause, Peter J. – sequence: 8 givenname: Christina surname: Brandeburg fullname: Brandeburg, Christina – sequence: 9 givenname: Christopher D. surname: Crowder fullname: Crowder, Christopher D. – sequence: 10 givenname: Heather E. surname: Carolan fullname: Carolan, Heather E. – sequence: 11 givenname: Mark W. surname: Eshoo fullname: Eshoo, Mark W. – sequence: 12 givenname: Pamela A. surname: Shaw fullname: Shaw, Pamela A. – sequence: 13 givenname: Linden T. surname: Hu fullname: Hu, Linden T. |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28351578$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/24523212$$D View this record in MEDLINE/PubMed |
BookMark | eNptkd1rFDEUxYNU7Ie--K4MSEGE0XuTySTxQajV2kLRBxV8C9lMZs0ym9QkU-h_b5Zday0-hATO7957bs4h2QsxOEKeIrxGUOyN9UM9RTH1gBwgZ6LtucK9-gYu204yuU8Oc14BIErgj8g-7ThlFOkB-fzDhTh4swwx-9yU2HxwxdnSvI8pucmbZjGn5RDT6JJvLsJYNR_D2-akOfMpl9aH9nxem9B8LfNw85g8HM2U3ZPdfUS-n338dnreXn75dHF6ctnajsvSLlzXO6CCAyhlLJfQmYGP2CngFns1IDLTSUQhRgeWgsDByoFKhG6EHtkRebftezUv1m6wLpRkJn2V_NqkGx2N1_8qwf_Uy3itmeK0B1YbvNw1SPHX7HLRa5-tmyYTXJyzRg5CKBRMVvTFPXQV5xTqepVCoEoJCpV6ftfRrZU_X12B4x1gsjXTmEywPv_lJOPIxWbcqy1nU8w5ufEWQdCbvHXNW2_zrjDcg6tgNgnVrf30_5Jn25JVLjHd8QkMe0HZb-IWtqM |
CODEN | CIDIEL |
CitedBy_id | crossref_primary_10_1016_j_idc_2015_02_012 crossref_primary_10_3390_microorganisms11092301 crossref_primary_10_3201_eid2906_221685 crossref_primary_10_3389_fmicb_2016_01744 crossref_primary_10_3390_antibiotics9090542 crossref_primary_10_1016_j_idc_2022_04_004 crossref_primary_10_1097_IM9_0000000000000115 crossref_primary_10_3389_fpubh_2021_819541 crossref_primary_10_1371_journal_pone_0189071 crossref_primary_10_3390_antibiotics8040269 crossref_primary_10_1128_cmr_00074_22 crossref_primary_10_1371_journal_pone_0225012 crossref_primary_10_3389_fmed_2023_1183344 crossref_primary_10_4236_wjns_2020_101001 crossref_primary_10_3390_ijms242316906 crossref_primary_10_3390_healthcare8030322 crossref_primary_10_3390_genes13091604 crossref_primary_10_1016_j_pt_2019_12_017 crossref_primary_10_1016_j_cmi_2024_10_014 crossref_primary_10_1093_pch_19_7_384 crossref_primary_10_1093_cid_cit942 crossref_primary_10_3389_fmicb_2016_00062 crossref_primary_10_1093_jme_tjv185 crossref_primary_10_1128_iai_00065_25 crossref_primary_10_3389_fneur_2021_628045 crossref_primary_10_1016_j_idc_2015_02_006 crossref_primary_10_1038_emi_2014_53 crossref_primary_10_1126_scitranslmed_ado2103 crossref_primary_10_3390_antibiotics7040089 crossref_primary_10_1177_2040622320922005 crossref_primary_10_1097_MOP_0000000000000167 crossref_primary_10_1016_j_ttbdis_2021_101782 crossref_primary_10_1080_10408363_2018_1450353 crossref_primary_10_1016_j_cmi_2015_11_009 crossref_primary_10_1016_j_crmicr_2020_05_003 crossref_primary_10_1016_j_epidem_2016_12_002 crossref_primary_10_3184_003685018X15360040523730 crossref_primary_10_1038_s41598_021_85624_5 crossref_primary_10_1371_journal_pone_0135828 crossref_primary_10_3389_fneur_2018_01048 crossref_primary_10_1093_infdis_jiaa719 crossref_primary_10_1111_jam_13523 crossref_primary_10_1128_IAI_00442_19 crossref_primary_10_3390_antibiotics6010010 crossref_primary_10_1093_jme_tjx250 crossref_primary_10_3389_fmed_2020_00006 crossref_primary_10_3389_fcimb_2020_00241 crossref_primary_10_1186_s12866_023_02935_5 crossref_primary_10_1007_s40471_016_0082_8 crossref_primary_10_1093_femsec_fix129 crossref_primary_10_3390_microbiolres15030088 crossref_primary_10_1097_NAN_0000000000000195 crossref_primary_10_1002_art_38756 crossref_primary_10_1111_1462_2920_13897 crossref_primary_10_1371_journal_pone_0117207 crossref_primary_10_3389_fmed_2017_00169 crossref_primary_10_3389_fmed_2021_666554 crossref_primary_10_3390_microorganisms11071759 crossref_primary_10_1038_nrneurol_2015_121 crossref_primary_10_1186_s12906_019_2450_7 crossref_primary_10_3389_fimmu_2024_1430419 crossref_primary_10_1128_AAC_00237_19 crossref_primary_10_1128_mbio_03440_21 crossref_primary_10_1586_14787210_2014_940900 crossref_primary_10_3238_arztebl_2018_0751 crossref_primary_10_1016_j_cmi_2019_06_033 crossref_primary_10_1038_s41598_020_59600_4 crossref_primary_10_3390_pathogens11050530 crossref_primary_10_1016_j_micinf_2017_06_002 crossref_primary_10_1016_j_pt_2015_03_008 crossref_primary_10_3390_antibiotics4030397 crossref_primary_10_1128_iai_00018_24 crossref_primary_10_1172_JCI138062 crossref_primary_10_1586_14787210_2014_966084 crossref_primary_10_3390_bios12100819 |
Cites_doi | 10.1093/jmedent/47.1.89 10.1056/NEJM200107123450202 10.1603/ME12038 10.1212/01.WNL.0000284604.61160.2d 10.1172/JCI58813 10.1128/JCM.38.6.2191-2199.2000 10.1002/art.30384 10.1078/1438-4221-00285 10.1086/315340 10.1128/AAC.01050-07 10.1371/journal.pone.0036825 10.1056/NEJMra072023 10.1128/JCM.30.12.3082-3088.1992 10.1089/vbz.2012.1012 10.1128/AAC.00788-09 10.1086/345284 10.1371/journal.pone.0029914 10.1128/CMR.00004-09 10.1128/JCM.01669-09 10.1371/journal.pone.0010650 10.1212/01.WNL.0000071227.23769.9E 10.1086/382594 10.1086/508667 10.1128/JCM.27.8.1723-1727.1989 10.1086/432935 10.4269/ajtmh.1987.36.92 10.1586/eri.10.174 |
ContentType | Journal Article |
Copyright | Copyright © 2014 Oxford University Press on behalf of the Infectious Diseases Society of America 2015 INIST-CNRS Copyright Oxford University Press, UK Apr 1, 2014 Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2014. This work is written by (a) US Government employee(s) and is in the public domain in the US. 2014 |
Copyright_xml | – notice: Copyright © 2014 Oxford University Press on behalf of the Infectious Diseases Society of America – notice: 2015 INIST-CNRS – notice: Copyright Oxford University Press, UK Apr 1, 2014 – notice: Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2014. This work is written by (a) US Government employee(s) and is in the public domain in the US. 2014 |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7QL 7T2 7T7 7U7 7U9 8FD C1K FR3 H94 K9. M7N P64 7X8 5PM |
DOI | 10.1093/cid/cit939 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Bacteriology Abstracts (Microbiology B) Health and Safety Science Abstracts (Full archive) Industrial and Applied Microbiology Abstracts (Microbiology A) Toxicology Abstracts Virology and AIDS Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Algology Mycology and Protozoology Abstracts (Microbiology C) Biotechnology and BioEngineering Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Virology and AIDS Abstracts Technology Research Database Toxicology Abstracts Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Health & Safety Science Abstracts Engineering Research Database Industrial and Applied Microbiology Abstracts (Microbiology A) Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE Virology and AIDS Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1537-6591 |
EndPage | 945 |
ExternalDocumentID | PMC3952603 3256864721 24523212 28351578 10_1093_cid_cit939 24031672 |
Genre | Research Support, N.I.H., Intramural Clinical Trial Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural Feature |
GrantInformation_xml | – fundername: NIAID NIH HHS grantid: 2R44AI077156 – fundername: Intramural NIH HHS – fundername: NIAID NIH HHS grantid: R21AI082436 – fundername: NIAID NIH HHS grantid: R21 AI082436 – fundername: NIAID NIH HHS grantid: R44 AI077156 |
GroupedDBID | --- ..I .2P .I3 .ZR 08P 0R~ 1KJ 1TH 29B 2AX 2WC 36B 4.4 48X 53G 5GY 5RE 5VS 5WD 6J9 70D AABZA AACGO AACZT AAJKP AAJQQ AAMVS AANCE AAOGV AAPNW AAPQZ AAPXW AAQQT AARHZ AAUAY AAUQX AAVAP ABBHK ABDFA ABEJV ABEUO ABGNP ABIXL ABJNI ABKDP ABLJU ABNHQ ABNKS ABOCM ABPLY ABPQP ABPTD ABQLI ABQNK ABTLG ABVGC ABWST ABXSQ ABXVV ABZBJ ACGFO ACGFS ACHIC ACPRK ACUFI ACUTJ ACUTO ACYHN ADBBV ADEYI ADGZP ADHKW ADHZD ADIPN ADNBA ADOCK ADQBN ADQXQ ADRTK ADULT ADVEK ADYVW ADZXQ AEGPL AEGXH AEJOX AEKSI AEMDU AEMQT AENEX AENZO AEPUE AETBJ AEUPB AEWNT AEXZC AFFZL AFIYH AFOFC AFRAH AFXAL AGINJ AGKEF AGORE AGQXC AGSYK AGUTN AHMBA AHMMS AHXPO AIAGR AIJHB AJBYB AJEEA AJNCP ALMA_UNASSIGNED_HOLDINGS ALUQC ALXQX APIBT APWMN AQKUS AQVQM ATGXG AXUDD BAWUL BAYMD BCRHZ BEYMZ BHONS BTRTY BVRKM C45 CDBKE CS3 CZ4 DAKXR DCCCD DIK DILTD DU5 D~K E3Z EBS EE~ EJD EMOBN ENERS F5P F9B FECEO FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC H13 H5~ HAR HW0 HZ~ IOX IPSME J21 JAAYA JBMMH JENOY JHFFW JKQEH JLS JLXEF JPM JSG JST JXSIZ KAQDR KBUDW KOP KSI KSN L7B MHKGH MJL ML0 N9A NGC NOMLY NOYVH NU- NVLIB O9- OAUYM OAWHX OCZFY ODMLO ODZKP OJQWA OJZSN OK1 OPAEJ OVD OWPYF P2P P6G PAFKI PEELM PQQKQ Q1. Q5Y QBD RD5 ROX ROZ RUSNO RW1 RXO SA0 SJN TCURE TEORI TJX TMA TR2 W8F X7H YAYTL YKOAZ YXANX ~91 ~S- AAYXX CITATION .GJ 3O- AAPGJ AAWDT AAYOK ABNGD ABSMQ ACFRR ACPQN ACUKT ACVCV ACZBC ADMTO AEKPW AFFNX AFFQV AFSHK AFYAG AGKRT AGMDO AI. AJDVS APJGH AQDSO ASPBG AVNTJ AVWKF AZFZN BZKNY C1A EIHJH FEDTE HQ3 HTVGU HVGLF IQODW J5H M49 MBLQV N4W O0~ OBFPC O~Y PB- VH1 Y6R ZGI AGQPQ AHGBF CGR CUY CVF ECM EIF NPM 7QL 7T2 7T7 7U7 7U9 8FD C1K FR3 H94 K9. M7N P64 7X8 5PM |
ID | FETCH-LOGICAL-c458t-be46e02750099ac5804ad5f14905c169d113a481177fe0c2071dc8d28104f0613 |
ISSN | 1058-4838 1537-6591 |
IngestDate | Thu Aug 21 18:07:57 EDT 2025 Fri Jul 11 15:34:41 EDT 2025 Mon Jun 30 07:16:46 EDT 2025 Mon Jul 21 05:50:56 EDT 2025 Wed Apr 02 07:24:41 EDT 2025 Tue Jul 01 04:19:53 EDT 2025 Thu Apr 24 23:11:15 EDT 2025 Fri Jun 20 01:32:54 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Keywords | Infection Human Borrelia burgdorferi Spirochaetaceae Spirochaetales Spirochaetosis Borrelia infection Bacteriosis Bacteria Lyme disease xenodiagnosis Ixodes scapularis human |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c458t-be46e02750099ac5804ad5f14905c169d113a481177fe0c2071dc8d28104f0613 |
Notes | SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-2 content type line 23 Presented in part: 2013 International Conference on Lyme Borreliosis and other Tick Borne Diseases, Boston, Massachusetts, 18–21 August 2013. Poster B040. |
OpenAccessLink | https://academic.oup.com/cid/article-pdf/58/7/937/17351643/cit939.pdf |
PMID | 24523212 |
PQID | 1510299720 |
PQPubID | 48300 |
PageCount | 9 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3952603 proquest_miscellaneous_1507791738 proquest_journals_1510299720 pubmed_primary_24523212 pascalfrancis_primary_28351578 crossref_primary_10_1093_cid_cit939 crossref_citationtrail_10_1093_cid_cit939 jstor_primary_24031672 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2014-04-01 |
PublicationDateYYYYMMDD | 2014-04-01 |
PublicationDate_xml | – month: 04 year: 2014 text: 2014-04-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Oxford |
PublicationPlace_xml | – name: Oxford – name: United States |
PublicationTitle | Clinical infectious diseases |
PublicationTitleAlternate | Clin Infect Dis |
PublicationYear | 2014 |
Publisher | OXFORD UNIVERSITY PRESS Oxford University Press |
Publisher_xml | – name: OXFORD UNIVERSITY PRESS – name: Oxford University Press |
References | Eshoo ( key 20170522094913_CIT939C26) 2012; 7 Schwartz ( key 20170522094913_CIT939C29) 1992; 30 Sinsky ( key 20170522094913_CIT939C14) 1989; 27 Wormser ( key 20170522094913_CIT939C16) 2009; 22 Centers for Disease Control and Prevention ( key 20170522094913_CIT939C19) Bockenstedt ( key 20170522094913_CIT939C28) 2012; 122 Straubinger ( key 20170522094913_CIT939C8) 2000; 181 Fallon ( key 20170522094913_CIT939C5) 2008; 70 Crowder ( key 20170522094913_CIT939C23) 2010; 47 Eshoo ( key 20170522094913_CIT939C27) 2010; 48 Bunikis ( key 20170522094913_CIT939C22) 2004; 189 Hua ( key 20170522094913_CIT939C15) 2003; 293 Feder ( key 20170522094913_CIT939C3) 2007; 357 Donahue ( key 20170522094913_CIT939C13) 1987; 36 Wormser ( key 20170522094913_CIT939C21) 2005; 41 Embers ( key 20170522094913_CIT939C12) 2012; 7 Li ( key 20170522094913_CIT939C30) 2011; 63 Wormser ( key 20170522094913_CIT939C2) 2006; 43 Centers for Disease Control and Prevention ( key 20170522094913_CIT939C1) Straubinger ( key 20170522094913_CIT939C7) 2000; 38 Crowder ( key 20170522094913_CIT939C25) 2010; 5 Bockenstedt ( key 20170522094913_CIT939C9) 2002; 186 Barthold ( key 20170522094913_CIT939C11) 2010; 54 Division of AIDS, NIAID ( key 20170522094913_CIT939C20) Klempner ( key 20170522094913_CIT939C4) 2001; 345 Krupp ( key 20170522094913_CIT939C6) 2003; 60 Wormser ( key 20170522094913_CIT939C17) 2012; 12 Wormser ( key 20170522094913_CIT939C18) 2011; 9 Hodzic ( key 20170522094913_CIT939C10) 2008; 52 Rounds ( key 20170522094913_CIT939C24) 2012; 49 24523213 - Clin Infect Dis. 2014 Apr;58(7):946-8 |
References_xml | – volume: 47 start-page: 89 year: 2010 ident: key 20170522094913_CIT939C23 article-title: Extraction of total nucleic acids from ticks for the detection of bacterial and viral pathogens publication-title: J Med Entomol doi: 10.1093/jmedent/47.1.89 – volume: 345 start-page: 85 year: 2001 ident: key 20170522094913_CIT939C4 article-title: Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease publication-title: N Engl J Med doi: 10.1056/NEJM200107123450202 – volume: 49 start-page: 843 year: 2012 ident: key 20170522094913_CIT939C24 article-title: Identification of endosymbionts in ticks by broad-range polymerase chain reaction and electrospray ionization mass spectrometry publication-title: J Med Entomol doi: 10.1603/ME12038 – volume: 70 start-page: 992 year: 2008 ident: key 20170522094913_CIT939C5 article-title: A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy publication-title: Neurology doi: 10.1212/01.WNL.0000284604.61160.2d – volume: 122 start-page: 2652 year: 2012 ident: key 20170522094913_CIT939C28 article-title: Spirochete antigens persist near cartilage after murine Lyme borreliosis therapy publication-title: J Clin Invest doi: 10.1172/JCI58813 – volume: 38 start-page: 2191 year: 2000 ident: key 20170522094913_CIT939C7 article-title: PCR-based quantification of Borrelia burgdorferi organisms in canine tissues over a 500-day postinfection period publication-title: J Clin Microbiol doi: 10.1128/JCM.38.6.2191-2199.2000 – volume: 63 start-page: 2238 year: 2011 ident: key 20170522094913_CIT939C30 article-title: Burden and viability of Borrelia burgdorferi in skin and joints of patients with erythema migrans or lyme arthritis publication-title: Arthritis Rheum doi: 10.1002/art.30384 – ident: key 20170522094913_CIT939C1 article-title: Lyme disease – ident: key 20170522094913_CIT939C19 article-title: 2011 Lyme disease case definition – volume: 293 start-page: 421 year: 2003 ident: key 20170522094913_CIT939C15 article-title: Early detection of Borrelia burgdorferi sensu lato infection in Balb/c mice by co-feeding Ixodes ricinus ticks publication-title: Int J Med Microbiol doi: 10.1078/1438-4221-00285 – volume: 181 start-page: 1069 year: 2000 ident: key 20170522094913_CIT939C8 article-title: Status of Borrelia burgdorferi infection after antibiotic treatment and the effects of corticosteroids: an experimental study publication-title: J Infect Dis doi: 10.1086/315340 – volume: 52 start-page: 1728 year: 2008 ident: key 20170522094913_CIT939C10 article-title: Persistence of Borrelia burgdorferi following antibiotic treatment in mice publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.01050-07 – ident: key 20170522094913_CIT939C20 article-title: National Institutes of Health table for grading adult and pediatric adverse experiences version 1.0—December 2004 (clarification dated August 2009) – volume: 7 start-page: e36825 year: 2012 ident: key 20170522094913_CIT939C26 article-title: Direct molecular detection and genotyping of Borrelia burgdorferi from whole blood of patients with early Lyme disease publication-title: PLoS One doi: 10.1371/journal.pone.0036825 – volume: 357 start-page: 1422 year: 2007 ident: key 20170522094913_CIT939C3 article-title: A critical appraisal of “chronic Lyme disease publication-title: N Engl J Med doi: 10.1056/NEJMra072023 – volume: 30 start-page: 3082 year: 1992 ident: key 20170522094913_CIT939C29 article-title: Diagnosis of early Lyme disease by polymerase chain reaction amplification and culture of skin biopsies from erythema migrans lesions publication-title: J Clin Microbiol doi: 10.1128/JCM.30.12.3082-3088.1992 – volume: 12 start-page: 535 year: 2012 ident: key 20170522094913_CIT939C17 article-title: Critical analysis of treatment trials of rhesus macaques infected with Borrelia burgdorferi reveals important flaws in experimental design publication-title: Vector Borne Zoonotic Dis doi: 10.1089/vbz.2012.1012 – volume: 54 start-page: 643 year: 2010 ident: key 20170522094913_CIT939C11 article-title: Ineffectiveness of tigecycline against persistent Borrelia burgdorferi publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00788-09 – volume: 186 start-page: 1430 year: 2002 ident: key 20170522094913_CIT939C9 article-title: Detection of attenuated, noninfectious spirochetes in Borrelia burgdorferi-infected mice after antibiotic treatment publication-title: J Infect Dis doi: 10.1086/345284 – volume: 7 start-page: e29914 year: 2012 ident: key 20170522094913_CIT939C12 article-title: Persistence of Borrelia burgdorferi in rhesus macaques following antibiotic treatment of disseminated infection publication-title: PLoS One doi: 10.1371/journal.pone.0029914 – volume: 22 start-page: 387 year: 2009 ident: key 20170522094913_CIT939C16 article-title: Antibiotic treatment of animals infected with Borrelia burgdorferi publication-title: Clin Microbiol Rev doi: 10.1128/CMR.00004-09 – volume: 48 start-page: 472 year: 2010 ident: key 20170522094913_CIT939C27 article-title: Detection and identification of Ehrlichia species in blood by use of PCR and electrospray ionization mass spectrometry publication-title: J Clin Microbiol doi: 10.1128/JCM.01669-09 – volume: 5 start-page: e10650 year: 2010 ident: key 20170522094913_CIT939C25 article-title: Genotypic variation and mixtures of Lyme Borrelia in Ixodes ticks from North America and Europe publication-title: PLoS One doi: 10.1371/journal.pone.0010650 – volume: 60 start-page: 1923 year: 2003 ident: key 20170522094913_CIT939C6 article-title: Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial publication-title: Neurology doi: 10.1212/01.WNL.0000071227.23769.9E – volume: 189 start-page: 1515 year: 2004 ident: key 20170522094913_CIT939C22 article-title: Borrelia burgdorferi infection in a natural population of Peromyscus leucopus mice: a longitudinal study in an area where Lyme borreliosis is highly endemic publication-title: J Infect Dis doi: 10.1086/382594 – volume: 43 start-page: 1089 year: 2006 ident: key 20170522094913_CIT939C2 article-title: The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America publication-title: Clin Infect Dis doi: 10.1086/508667 – volume: 27 start-page: 1723 year: 1989 ident: key 20170522094913_CIT939C14 article-title: Ear punch biopsy method for detection and isolation of Borrelia burgdorferi from rodents publication-title: J Clin Microbiol doi: 10.1128/JCM.27.8.1723-1727.1989 – volume: 41 start-page: 958 year: 2005 ident: key 20170522094913_CIT939C21 article-title: Prospective clinical evaluation of patients from Missouri and New York with erythema migrans-like skin lesions publication-title: Clin Infect Dis doi: 10.1086/432935 – volume: 36 start-page: 92 year: 1987 ident: key 20170522094913_CIT939C13 article-title: Reservoir competence of white-footed mice for Lyme disease spirochetes publication-title: Am J Trop Med Hyg doi: 10.4269/ajtmh.1987.36.92 – volume: 9 start-page: 245 year: 2011 ident: key 20170522094913_CIT939C18 article-title: Treatment of infection caused by Borrelia burgdorferi sensu lato publication-title: Expert Rev Anti Infect Ther doi: 10.1586/eri.10.174 – reference: 24523213 - Clin Infect Dis. 2014 Apr;58(7):946-8 |
SSID | ssj0011805 |
Score | 2.4416625 |
Snippet | Background. Animal studies suggest that Borrelia burgdorferi, the agent of Lyme disease, may persist after antibiotic therapy and can be detected by various... Animal studies suggest that Borrelia burgdorferi, the agent of Lyme disease, may persist after antibiotic therapy and can be detected by various means... Xenodiagnosis using Ixodes scapularis larvae in humans is safe and well tolerated. There is no evidence of persistence of infection after antibiotic therapy in... |
SourceID | pubmedcentral proquest pubmed pascalfrancis crossref jstor |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 937 |
SubjectTerms | and Commentaries Animals Antibiotics Arachnid Vectors - microbiology ARTICLES AND COMMENTARIES Bacterial diseases Biological and medical sciences Biopsies Borrelia burgdorferi Borrelia burgdorferi - genetics Borrelia burgdorferi - isolation & purification Borrelia infections Erythema multiforme Female Glossitis, Benign Migratory - microbiology Human bacterial diseases Humans Infections Infectious diseases Ixodes - microbiology Lyme disease Lyme Disease - diagnosis Lyme Disease - transmission Male Medical diagnosis Medical sciences Medical treatment Mice Mice, SCID Middle Aged Polymerase chain reaction Ticks Tropical bacterial diseases Xenodiagnosis Xenodiagnosis - methods |
Title | Xenodiagnosis to Detect Borrelia burgdorferi Infection: A First-in-Human Study |
URI | https://www.jstor.org/stable/24031672 https://www.ncbi.nlm.nih.gov/pubmed/24523212 https://www.proquest.com/docview/1510299720 https://www.proquest.com/docview/1507791738 https://pubmed.ncbi.nlm.nih.gov/PMC3952603 |
Volume | 58 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwELaqISFeEAMGhTEFwQuawuIkdmLeBls1YC1ITaW-RYnjiEglRW36sn-Bf5pzrnYTqCbgJaoaK7_u8vku_u47Ql6HPAgKRX3XD2PPDQEk3Vy3DCuL0AtEKUTEdIHzeMKvZuGnOZsPBj87rKVNk7-VN3vrSv7HqvAf2FVXyf6DZe1B4Q_4DfaFLVgYtn9l47mqlwVy5apWqeFC6TWB0_e65caiyk71GkqxXJVwMYAESLuqsRh9VEHc51a1i5_xp1Zm1sgWmJJJQ9farM1qjg3Dx9lKTystvhRwv7XF-EQtDGt-mn3fsRKTDVKzp9XG_WpmTWxKhaADuFx3v0TQLoHllgrHDrh6rP14iXirDOBGLmfYscsgMos7nhd14FWgQMwfsI-SWLI1s6wagfpIfXXtyZd0NLu-TpPLedLfi7M5xH6x1tKHVPqODzmHRvmLj5_tkhSNWz6svQmjdSuCMzjxGZ62F90gwVWzbbM12KvETin7UpnfGbmdECd5QO5vcxPnHB3tkAxU_ZDcHW_ZF4_IpOdvTrN00N8c429Ox98c62_vnHOn721O622PyWx0mXy4crf9OFwZsrhxcxVypZe5dVqRSRZ7YVawEnJsj0nKRUFpkIW6cjkqlSd9iF4LGRd-DCl_qePGI3JQL2v1lDiSM1XCZKK4kGHpi5xJLoOcRxAQZxGjQ_LGPMdUbsXqdc-URYqkiSDVHafxmQ_JKzv2B0q07B111JrDDtFClJRH_pCc9OyzGwDJCYUJbUiOjcHS7cu_TiFQ9nxddO4NyUu7G6BZr7dltYKXMtW5ViRoFMAhnqB9O2dnkMtQOHvUs7wdoGXf-3vq6lsr_x4I5nMveHb7ZT0n93bv6DE5aFYb9QLi5yY_af36F7WAyJg |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Xenodiagnosis+to+Detect+Borrelia+burgdorferi+Infection%3A+A+First-in-Human+Study&rft.jtitle=Clinical+infectious+diseases&rft.au=Marques%2C+Adriana&rft.au=Telford%2C+Sam+R&rft.au=Turk%2C+Siu-Ping&rft.au=Chung%2C+Erin&rft.date=2014-04-01&rft.pub=Oxford+University+Press&rft.issn=1058-4838&rft.eissn=1537-6591&rft.volume=58&rft.issue=7&rft.spage=937&rft_id=info:doi/10.1093%2Fcid%2Fcit939&rft.externalDBID=NO_FULL_TEXT&rft.externalDocID=3256864721 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1058-4838&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1058-4838&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1058-4838&client=summon |